Brought to you by:
Positive one-year data for new venous valve portends promising future in chronic venous insufficiency treatment
SAVVE trial principal investigators discuss results showing 98.4% VenoValve device patency, 85% clinically meaningful benefit and an 80% rate of ulcer size reduction at 12 months. Fresh from delivering positive one-year data from the Surgical Antireflux Venous Valve Endoprosthesis (SAVVE)…
Service: Giving back
Pioneering American Venous Forum (AVF) and Eastern Vascular Society (EVS) efforts aimed at breaking down barriers to care and educating patients in economically challenged communities on vascular disease have yielded early gains over the first two events staged this year.…
One-year data from VenoValve US pivotal trial emerges
Envveno Medical has announced that it will present one-year data on all patients from the VenoValve US pivotal trial today at the VEITHsymposium (19–23 November, New York, USA). The definitive one-year data support the application submitted earlier this week by Envveno Medical seeking…
VenaCore device offers long-awaited interventional solution for challenging venous occlusions
This advertorial is sponsored by Inari Medical. Despite the recent growth in mechanical thrombectomy devices for acute deep vein thrombosis (DVT), interventional options for wall adherent venous obstruction are extremely limited. Residual venous obstruction after medical or interventional therapy for…
Pilot study looks at undiagnosed vascular disease in homeless
A pilot study in Canadian capital Ottawa aimed at uncovering the extent of undiagnosed vascular disease among the city’s homeless population detected a subset who may be in need of treatment for venous disease. The work was carried out by…
First-in-human study of SonoThrombectomy system completed
SonoVascular has announced the successful initiation of its first-in-human study (FIH) of the company’s SonoThrombectomy system, an ultrasound-facilitated, thrombolytic-enhanced platform that utilizes multiple mechanisms of action to treat patients with venous thromboembolism (VTE). The catheter-based system combines microbubble-mediated cavitation with…
Eastern Vascular Society set to stage day of service during 2024 annual meeting
The Eastern Vascular Society (EVS) has incorporated a day of service into its 2024 annual meeting, being held in Charleston, South Carolina (Sept. 19–22). Leading vascular surgeons, alongside nurse practitioners and advanced practice partners, will educate local residents about their…
SVS, AVF bring the latest innovations in venous disease treatment to VAM
During the first day of VAM 2024, the Society for Vascular Surgery (SVS) and American Venous Forum (AVF) have co-sponsored a session on the latest innovations in the delivery of venous disease treatment. Madhavi Meka, MD, a clinical associate professor…
‘The forgotten stepchild of vascular surgery’: The quest to push forward basic science research in venous disease
The 2024 Venous Symposium (May 8–11) in New York City was highlighted by keynote speaker Peter Pappas, MD, regional medical director and program director of the venous and lymphatic medicine fellowship at the Center for Vein Restoration in Morristown and…
New randomised data show cyanoacrylate glue performs strongly on patient satisfaction
Patients undergoing cyanoacrylate glue closure for superficial venous disease reported higher periprocedural satisfaction than those who were treated via surgical stripping, data from a pair of randomised controlled trials (RCTs) assessing the VenaSeal system (Medtronic) reveal. The modality also showed…